Company Financials

Neuren Pharmaceuticals Limited Financials

Australian dollar

business Neuren Pharmaceuticals Limited Company Profile

Main Stock Listing

ASX: NEU

Market Capitalization A$2.60 Billion as of July 1, 2024

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE 15.98
Forward PE 25.57
Price to Sales TTM A$10.75
Price to Book MRQ A$11.90
Enterprise to Revenue 9.47
Enterprise to EBITDA 11.03

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2023-12-31
Profit Margin 67.72%
Operating Margin 89.40%
Return on Assets TTM 85.52%
Return on Equity TTM 127.30%

Income Statement

Revenue TTM A$231,942,000
Revenue per Share TTM A$1.83
Quarterly Revenue Growth 996.30%
Gross Profit TTM A$231,925,000
EBITDA A$199,228,000
Net Income to Common TTM A$157,080,992
Diluted EPS TTM A$1.20
Quarterly Earnings Growth YoY 1409.80%

Balance Sheet

Total Cash MRQ A$228,539,008
Total Cash per Share MRQ A$1.80
Total Debt MRQ A$
Total Debt to Equity MRQ 0.00
Current Ratio MRQ 5.78
Book Value per Share MRQ A$1.61

Cash Flow

Operating Cash Flow TTM A$184,924,992
Levered Free Cash Flow TTM A$152,967,120

NEU Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 129,946,000
Float Shares 108,841,424
Avg 10 Volume 319,841
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 13.30%
% Held by Institutions 17.14%

Stock Price Summary

Beta 1.99
Fifty Two Week Low A$10.02
Fifty Two Week High A$25.95
Fifty Two Week Change 29.70%
Day 50 MA A$20.17
Day 200 MA A$17.07

Dividends and Splits

Forward Annual Dividend Rate A$
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate A$0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2017-11-20